Translation enhancer improves the ribosome liberation from translation initiation. 2013

Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
Department of Biomolecular Engineering, Tokyo Institute of Technology, B-53, 4259 Nagatsuda, Midori-ku, Yokohama 226-8501, Japan.

For translation initiation in bacteria, the Shine-Dalgarno (SD) and anti-SD sequence of the 30S subunit play key roles for specific interactions between ribosomes and mRNAs to determine the exact position of the translation initiation region. However, ribosomes also must dissociate from the translation initiation region to slide toward the downstream sequence during mRNA translation. Translation enhancers upstream of the SD sequences of mRNAs, which likely contribute to a direct interaction with ribosome protein S1, enhance the yields of protein biosynthesis. Nevertheless, the mechanism of the effect of translation enhancers to initiate the translation is still unknown. In this paper, we investigated the effects of the SD and enhancer sequences on the binding kinetics of the 30S ribosomal subunits to mRNAs and their translation efficiencies. mRNAs with both the SD and translation enhancers promoted the amount of protein synthesis but destabilized the interaction between the 30S subunit and mRNA by increasing the dissociation rate constant (koff) of the 30S subunit. Based on a model for kinetic parameters, a 16-fold translation efficiency could be achieved by introducing a tandem repeat of adenine sequences (A20) between the SD and translation enhancer sequences. Considering the results of this study, translation enhancers with an SD sequence regulate ribosomal liberation from translation initiation to determine the translation efficiency of the downstream coding region.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D012270 Ribosomes Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION. Ribosome
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
June 2012, Current protein & peptide science,
Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
September 2020, Nucleic acids research,
Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
January 2001, Cold Spring Harbor symposia on quantitative biology,
Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
January 1995, Virology,
Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
August 2017, BMC biology,
Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
February 2013, Nature structural & molecular biology,
Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
June 2009, Molecular microbiology,
Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
February 2000, Oncogene,
Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
December 2016, RNA biology,
Shuntaro Takahashi, and Hiroyuki Furusawa, and Takuya Ueda, and Yoshio Okahata
December 2000, IUBMB life,
Copied contents to your clipboard!